Upgrade
| ShowHide Related Items >><< - 04/17/23
- Elevation Oncology presents EO-3021 preclinical PoC data
- 01/06/23
- Elevation Oncology realigns resources, CEO resigns, cuts workforce by 30%
- 11/10/22 JPMorgan
- Elevation downgraded to Underweight on more difficult path at JPMorgan
- 11/10/22 JPMorgan
- Elevation Oncology downgraded to Underweight from Neutral at JPMorgan
- 11/07/22 SVB Securities
- Elevation Oncology downgraded to Market Perform from Outperform at SVB Securities
- 09/19/22 H.C. Wainwright
- Elevation Oncology assumed with a Buy at H.C. Wainwright
- 05/15/23
- Elevation Oncology reports Q1 EPS (72c), consensus (59c)
- 03/09/23
- Elevation Oncology reports Q4 EPS (82c0, consensus (78c)
|
Hot Stocks
| ShowHide Related Items >><< - 05/15/23
- Tiger Global buys TSMC, exits AppLovin in Q1
- 05/10/23
- AppLovin jumps 12% to $19.96 after Q1 results, above-consensus guidance
- 05/01/23
- AppLovin expands Google bidding's open beta to all MAX publishers
- 03/13/23
- AppLovin confirms Silicon Valley exposure minimal with less than $2M
- 05/17/23 BofA
- AppLovin upgraded to Buy at BofA after Q1 pricing surge
- 05/17/23 BofA
- AppLovin upgraded to Buy from Neutral at BofA
- 05/12/23 Truist
- AppLovin price target raised to $25 from $20 at Truist
- 05/11/23 DA Davidson
- AppLovin price target raised to $32 from $28 at DA Davidson
- 05/10/23
- AppLovin sees Q2 revenue $710M-$730M, consensus $696.8M
- 05/10/23
- AppLovin reports Q1 EPS (1c), consensus 7c
- 05/10/23
- Notable companies reporting after market close
- 02/08/23
- AppLovin sees Q1 revenue $685M-$705M, consensus $682.2M
- 05/17/23
- What You Missed On Wall Street On Wednesday
- 05/17/23
- What You Missed On Wall Street This Morning
- 05/17/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/11/23
- What You Missed On Wall Street On Thursday
- 05/17/23
- Applovin call volume above normal and directionally bullish
- 05/10/23
- Applovin options imply 12.9% move in share price post-earnings
- 02/08/23
- Applovin options imply 13.1% move in share price post-earnings
|
Hot Stocks
| ShowHide Related Items >><< - 05/25/23
- Stratasys to review unsolicited special tender offer from Nano Dimension
- 05/25/23
- Nano Dimension launches $18.00 all-cash offer to increase Stratasys stake
- 05/25/23
- Nano Dimension launches $18.00 all-cash offer to increase Stratasys stake
- 05/25/23
- Stratasys to combine with Desktop Metal in $1.8B all-stock transaction
- 05/25/23
- Stratasys to review unsolicited special tender offer from Nano Dimension
- 05/25/23
- Nano Dimension launches $18.00 all-cash offer to increase Stratasys stake
- 05/25/23
- Nano Dimension launches $18.00 all-cash offer to increase Stratasys stake
- 04/27/23
- Nano Dimension to showcase Micro-AM progress at RAPID + TCT
- 05/26/23 William Blair
- Stratasys acquisition of Desktop could be a mistake, says William Blair
- 05/25/23 Lake Street
- Stratasys deal 'appears to be total desperation move,' says Lake Street
- 05/17/23 Lake Street
- Stratasys price target trimmed to $21 at Lake Street after 'solid quarter'
- 03/10/23 Lake Street
- Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
- 05/25/23 Lake Street
- Stratasys deal 'appears to be total desperation move,' says Lake Street
- 03/10/23 Lake Street
- Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
- 05/25/23
- Stratasys backs FY23 EPS view 12c-24, consensus 17c
- 05/16/23
- Stratasys sees FY23 EPS 12c-24c, consensus 16c
- 05/16/23
- Stratasys reports Q1 EPS 2c, consensus (6c)
- 03/02/23
- Stratasys sees FY23 EPS 12c-24c, consensus 20c
- 04/10/23
- Nano Dimension see Q1 revenue $14.6M, up 40% vs. last year
- 03/30/23
- Nano Dimension reports Q4 EPS (34c) vs. (62c) last year
- 01/24/23
- Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21
- 12/01/22
- Nano Dimension reports Q3 EPS (26c) vs. (7c) last year
- 05/24/23
- Stratasys in talks to buy Desktop Metal in all-stock deal, Bloomberg says
- 05/24/23
- Desktop Metal, Stratasys deal to be announced this week, Bloomberg says
- 05/24/23
- Stratasys in talks to buy Desktop Metal, Bloomberg says
- 03/07/23
- Nano Dimension receives purchase order for DragonFly IV system
- 05/25/23
- What You Missed On Wall Street On Thursday
- 05/25/23
- What You Missed On Wall Street This Morning
- 05/25/23
- Fly Intel: Pre-market Movers
- 05/16/23
- What You Missed On Wall Street On Tuesday
- 04/10/23
- What You Missed On Wall Street This Morning
- 03/30/23
- What You Missed On Wall Street On Thursday
- 03/30/23
- What You Missed On Wall Street This Morning
- 03/29/23
- What You Missed On Wall Street On Wednesday
- 03/07/23
- Unusually active option classes on open March 7th
- 01/20/23
- Largest borrow rate increases among liquid names
|
Upgrade
|
Vertical Research analyst… ShowHide Related Items >><< - $159.33 /
-1.055 (-0.66%) - 05/15/23
- Heico to acquire Wencor Group for $1.9B in cash, $150M in Class A common stock
- 04/03/23
- Heico's Dukane Seacom enters exclusive license agreement with Honeywell
- 02/27/23
- Heico sees net sales growth in both operating segments in FY23
- 12/19/22
- HEICO raises semi-annual cash dividend 11% to 10c per share
- $159.33 /
-1.055 (-0.66%) - 05/15/23 Morgan Stanley
- TransDigm price target raised to $1,000 from $793 at Morgan Stanley
- 04/03/23 BofA
- Heico price target raised to $190 from $162 at BofA
- 03/01/23 Truist
- Heico price target raised to $190 from $169 at Truist
- 02/27/23 Jefferies
- Heico price target raised to $205 from $180 at Jefferies
- $159.33 /
-1.055 (-0.66%) - 05/22/23
- Heico reports Q2 EPS 76c, consensus 73c
- 02/27/23
- Heico reports Q1 EPS 67c, consensus 69c
- 12/19/22
- Heico reports Q4 EPS 70c, consensus 69c
|
Recommendations
|
Citi says President Biden… ShowHide Related Items >><< - 05/24/23
- HII reports $305.2M contract modification from General Dynamics Electric Boat
- 05/23/23
- General Dynamics NASSCO awarded $736M contract
- 05/23/23
- General Dynamics awarded $1.08B Navy contract action modification
- 05/22/23
- General Dynamics awarded $736.16M Navy contract modification
- 05/11/23
- Nauticus Robotics, Leidos executes $2.7M contract extension
- 05/01/23
- TFF Pharmaceuticals receives additional funding from Leidos
- 04/25/23
- PureCycle Ironton PP purification plant reaches mechanical completion
- 04/18/23
- Leidos awarded a new prime contract from U.S. Marine Corps
- $448.57 /
+6.025 (+1.36%) - 05/23/23
- Lockheed Martin awarded $194.74M Navy contract
- 05/19/23
- Lockheed Martin announces Blue Origin team selected to develop lunar lander
- 05/19/23
- NASA selects Blue Origin as second Artemis lunar lander provider
- 05/19/23
- Blue Origin, Lockheed, Boeing win NASA contract to build second lunar lander
- 05/23/23
- U.S. Navy awards SAIC $249M contract to support NAWCWD's platforms
- 05/18/23
- SAIC names Toni Townes-Whitley CEO
- 04/25/23
- SAIC awarded $889M contract by FEDSIM
- 04/18/23
- SAIC and GomSpace announce strategic partnership
- 05/04/23 Bernstein
- General Dynamics price target lowered to $245 from $251 at Bernstein
- 04/27/23 RBC Capital
- General Dynamics price target lowered to $270 from $280 at RBC Capital
- 04/27/23 Wells Fargo
- General Dynamics price target lowered to $251 from $265 at Wells Fargo
- 04/27/23 Baird
- General Dynamics price target lowered to $242 from $268 at Baird
- 05/25/23 Wells Fargo
- Wells Fargo upgrades Leidos to Overweight, raises price target to $102
- 05/25/23 Wells Fargo
- Leidos upgraded to Overweight from Equal Weight at Wells Fargo
- 05/16/23 Stifel
- Leidos price target lowered to $113 from $114 at Stifel
- 05/09/23 Barclays
- Leidos price target lowered to $90 from $113 at Barclays
- $448.57 /
+6.025 (+1.36%) - 04/20/23 Bernstein
- Lockheed Martin price target raised to $496 from $478 at Bernstein
- 04/19/23 Credit Suisse
- Lockheed Martin price target raised to $550 from $510 at Credit Suisse
- 04/19/23 Citi
- Lockheed Martin price target raised to $579 from $546 at Citi
- 04/12/23 Baird
- Lockheed Martin downgraded to Neutral at Baird ahead of earnings
- 04/11/23 Stifel
- SAIC price target raised to $112 from $110 at Stifel
- 04/05/23 Goldman Sachs
- SAIC price target raised to $97 from $90 at Goldman Sachs
- 04/04/23 Citi
- SAIC price target lowered to $127 from $141 at Citi
- 03/30/23 William Blair
- William Blair learned Verizon teaming with SAIC on big FAA contract
- 04/26/23
- General Dynamics reports Q1 EPS $2.64, consensus $2.59
- 04/25/23
- Notable companies reporting before tomorrow's open
- 04/25/23
- Notable companies reporting before tomorrow's open
- 01/25/23
- General Dynamics sees FY23 EPS $12.60-$12.65, consensus $13.90
- 05/02/23
- Leidos backs FY23 EPS view $6.40-$6.80, consensus $6.70
- 05/02/23
- Leidos reports Q1 EPS $1.47, consensus $1.58
- 02/14/23
- Leidos sees FY23 EPS $6.40-$6.80, consensus $6.81
- 02/14/23
- Leidos reports Q4 adjusted EPS $1.83, consensus $1.61
- $448.57 /
+6.025 (+1.36%) - 04/18/23
- Lockheed Martin reports Q1 adjusted EPS $6.43, consensus $6.06
- 04/18/23
- Lockheed Martin backs FY23 EPS view about $26.60-$26.90, consensus $26.77
- 04/18/23
- Lockheed Martin reports Q1 EPS $6.61, consensus $6.06
- 04/17/23
- Notable companies reporting before tomorrow's open
- 04/11/23
- SAIC sees FY26 adjusted EPS $8.50-$8.70, revenue $7.3B-$7.5B
- 04/11/23
- SAIC sees FY25 adjusted EPS $7.60-$7.80, consensus $7.60
- 04/11/23
- SAIC sees FY24 adjusted EPS $6.80-$7.00, consensus $6.95
- 04/03/23
- SAIC guides FY24 EPS $6.80-$7.00, consensus $7.48
- 03/07/23
- Biden to propose Pentagon budget of over $835B, Bloomberg says
- 01/06/23
- McCarthy's speaker deal includes $75B defense cut, Bloomberg reports
- 01/04/23
- Lagging arms production raises concerns over industry consolidation, WSJ report
- $448.57 /
+6.025 (+1.36%) - 05/18/23
- USAF opens multibillion-dollar contest for new fighter aircraft, Bloomberg says
- 05/14/23
- Space could be a $1T business, Barron's says
- 04/25/23
- NASA selects Boeing, Aerojet, others to collaborate on key tech development
- 04/18/23
- China bans Raytheon, Lockheed executives from country, Reuters says
- 04/26/23
- Fly Intel: Pre-market Movers
- 03/30/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/25/23
- What You Missed On Wall Street On Wednesday
- 01/25/23
- What You Missed On Wall Street This Morning
- 05/25/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/14/23
- Fly Intel: Pre-market Movers
- 12/08/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- $448.57 /
+6.025 (+1.36%) - 04/18/23
- What You Missed On Wall Street On Tuesday
- 04/18/23
- What You Missed On Wall Street This Morning
- 04/18/23
- Fly Intel: Pre-market Movers
- 04/12/23
- What You Missed On Wall Street On Wednesday
- 04/11/23
- What You Missed On Wall Street On Tuesday
- 04/11/23
- What You Missed On Wall Street This Morning
- 04/03/23
- What You Missed On Wall Street On Monday
- 04/03/23
- What You Missed On Wall Street This Morning
- $448.57 /
+6.025 (+1.36%) - 04/18/23
- Early notable gainers among liquid option names on April 18th
- 02/13/23
- Unusually active option classes on open February 13th
- 01/24/23
- Unusually active option classes on open January 24th
|
Recommendations
| ShowHide Related Items >><< - 05/26/23
- Lowe's announces 5% increase to quarterly cash dividend to $1.10 per share
- 05/26/23
- Lowe's raises quarterly dividend 5% to $1.10 from $1.05 per share
- 05/24/23
- Lowe's FY EPS likely to be 'roughly flattish,' says Pershing Square
- 05/24/23
- Lowe's announces new one-stop shop concept
- $292.81 /
+6.045 (+2.11%) - 05/16/23
- Home Depot says still seeing inflation in average ticket
- 05/16/23
- Home Depot says big ticket comps down 6.5% y/y in Q1
- 05/16/23
- Home Depot says observed more pressure across business vs. Q4
- 03/14/23
- Home Depot names William Bastek EVP of merchandising, effective immediately
- 05/25/23 Argus
- Lowe's price target lowered to $250 from $290 at Argus
- 05/24/23 Piper Sandler
- Lowe's price target lowered to $230 from $235 at Piper Sandler
- 05/24/23 Truist
- Lowe's price target lowered to $229 from $235 at Truist
- 05/24/23 DA Davidson
- Lowe's price target raised to $237 from $228 at DA Davidson
- $292.81 /
+6.045 (+2.11%) - 05/24/23 DA Davidson
- Lowe's price target raised to $237 from $228 at DA Davidson
- 05/24/23 Wedbush
- Lowe's price target raised to $210 from $200 at Wedbush
- 05/23/23 DA Davidson
- Lowe's comps beats Home Depot for first time since Q4 of 2020, says DA Davidson
- 05/19/23 Oppenheimer
- Home Depot price target lowered to $360 from $400 at Oppenheimer
- 05/23/23
- Lowe's sees $400M headwind to Q2 sales
- 05/23/23
- Lowe's cuts FY23 EPS view to $13.20-$13.60 from 13.60-$14.00, consensus $13.73
- 05/23/23
- Lowe's reports Q1 adjusted EPS $3.67, consensus $3.44
- 05/22/23
- Notable companies reporting before tomorrow's open
- $292.81 /
+6.045 (+2.11%) - 05/16/23
- Home Depot cuts FY23 EPS view to down 7%-13% from down mid-single digits percent
- 05/16/23
- Home Depot reports Q1 EPS $3.82, consensus $3.80
- 05/15/23
- Notable companies reporting before tomorrow's open
- 05/15/23
- Notable companies reporting before tomorrow's open
- 01/28/23
- Lowe's is catching up to Home Depot, stock price to follow, Barron's says
- $292.81 /
+6.045 (+2.11%) - 01/28/23
- Lowe's is catching up to Home Depot, stock price to follow, Barron's says
- 05/23/23
- What You Missed On Wall Street On Tuesday
- 05/23/23
- What You Missed On Wall Street This Morning
- 05/23/23
- Fly Intel: Pre-market Movers
- 05/15/23
- Here's what Wall Street is saying about Home Depot, Lowe's ahead of earnings
- $292.81 /
+6.045 (+2.11%) - 05/16/23
- What You Missed On Wall Street On Tuesday
- 05/16/23
- What You Missed On Wall Street This Morning
- 05/16/23
- Fly Intel: Pre-market Movers
- 05/15/23
- Here's what Wall Street is saying about Home Depot, Lowe's ahead of earnings
- 05/23/23
- Unusually active option classes on open May 23rd
- 05/16/23
- Unusually active option classes on open May 16th
- 05/04/23
- Lowe's put volume heavy and directionally bearish
- 04/24/23
- Lowe's put volume heavy and directionally bearish
- $292.81 /
+6.045 (+2.11%) - 05/19/23
- Home Depot put volume heavy and directionally bearish
- 05/16/23
- Unusually active option classes on open May 16th
- 03/17/23
- Home Depot call volume above normal and directionally bullish
- 02/21/23
- Unusually active option classes on open February 21st
|
Conference/Events
| ShowHide Related Items >><< - 04/26/23
- Sportradar names Griffin as Chief Financial Officer
- 04/24/23
- Sportradar announces nomination of two new directors
- 03/13/23
- Sportradar wins bid for ATP data, betting streaming rights
- 02/01/23
- Sportradar appoints Riviere as Chief People Officer
- 05/16/23 BofA
- Sportradar price target raised to $11.50 from $10 at BofA
- 03/16/23 Deutsche Bank
- Sportradar price target lowered to $13 from $14 at Deutsche Bank
- 03/16/23 Needham
- Sportradar price target lowered to $15 from $17 at Needham
- 03/16/23 Canaccord
- Sportradar price target lowered to $18 from $20 at Canaccord
- 05/10/23
- Sportradar sees FY23 revenue $983.2M-$1.003B, consensus $1B
- 05/10/23
- Sportradar reports Q1 EPS EUR 0c vs EUR 0c last year
- 03/15/23
- Sportradar sees FY23 revenue $965.1M-$984.4M, consensus $936.11M
- 03/15/23
- Sportradar reports Q4 revenue $220.7M, consensus $208.09M
- 05/19/23
- Bet On It: Fanatics buys U.S. operations from PointsBet
- 05/12/23
- Bet On It: Churchill Downs posts all-time high Kentucky Derby wagers
- 04/28/23
- Bet On It: DraftKings to launch video streaming service
- 03/31/23
- Bet On It: Gan Limited shrinks following initiation of strategic review
|
Conference/Events
|
Meeting to be held in San… ShowHide Related Items >><< - 05/25/23
- Medtronic to acquire EOFlow for $738M
- 05/25/23
- Medtronic increases quarterly dividend to 69c per share
- 05/21/23
- Medtronic announces follow-up results of investigational EV ICD system
- 05/01/23
- Medtronic receives FDA approval for next-gen Micra leadless pacing systems
- 05:41 Today Morgan Stanley
- Medtronic assumed with Overweight from Equal Weight at Morgan Stanley
- 05/26/23 Truist
- Medtronic price target lowered to $90 from $93 at Truist
- 05/26/23 Stifel
- Medtronic price target raised to $92 from $90 at Stifel
- 05/26/23 Bernstein
- Medtronic price target lowered to $99 from $100 at Bernstein
- 05/25/23
- Medtronic sees FY24 EPS $5.00-$5.10, consensus $5.20
- 05/25/23
- Medtronic reports Q4 EPS $1.57, consensus $1.56
- 02/21/23
- Medtronic sees Q4 EPS $1.55-$1.57, consensus $1.58
- 02/21/23
- Medtronic narrows FY23 EPS view to $5.28-$5.30 from $5.25-$5.30
- 05/10/23
- New suitors showing interest in ShockWave Medical, Street Insider says
- 03/29/23
- ICU teams with Linden Capital for Medtronic assets bid, Reuters reports
- 02/22/23
- Apple hits breakthroughs in glucose monitoring project, Bloomberg reports
- 02/08/23
- Apple names Medtronic's Surface as Chief People Officer, Bloomberg says
- 05/25/23
- What You Missed On Wall Street On Thursday
- 05/25/23
- What You Missed On Wall Street This Morning
- 04/28/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 04/24/23
- What You Missed On Wall Street On Monday
- 05/25/23
- Unusually active option classes on open May 25th
- 04/24/23
- Early notable gainers among liquid option names on April 24th
- 04/24/23
- Unusually active option classes on open April 24th
- 02/09/23
- Medtronic put volume heavy and directionally bearish
|
Initiation
| ShowHide Related Items >><< VRTX Vertex Pharmaceuticals - 05/03/23
- Vertex announces FDA approval for KALYDECO to treat eligible infants with CF
- 04/26/23
- Vertex announces U.S. FDA approval for expanded use of Trikafta
- 04/25/23
- Stablix, Vertex collaborate for targeted protein stabilization therapeutics
- 04/10/23
- Sana Biotechnology CMO Sunil Agarwal to leave, Gary Meininger to succeed
VRTX Vertex Pharmaceuticals - 05/25/23 WestPark Capital
- Vertex Pharmaceuticals initiated with a Hold at WestPark Capital
- 05/04/23 Piper Sandler
- Vertex Pharmaceuticals assumed with an Overweight at Piper Sandler
- 05/03/23 Maxim
- Vertex Pharmaceuticals price target raised to $400 from $325 at Maxim
- 05/03/23 Bernstein
- Vertex Pharmaceuticals price target raised to $363 from $344 at Bernstein
VRTX Vertex Pharmaceuticals - 05/01/23
- Vertex Pharmaceuticals backs FY23 revenue view of $9.55B-$9.7B, consensus $9.71B
- 05/01/23
- Vertex Pharmaceuticals reports Q1 EPS $2.69, consensus $3.00
- 02/07/23
- Vertex Pharmaceuticals guides FY23 revenue $9.55B-$9.70B, consensus $9.6B
- 02/07/23
- Vertex Pharmaceuticals reports Q4 EPS $3.76, consensus $3.51
VRTX Vertex Pharmaceuticals - 02/07/23
- Vertex keeps cystic fibrosis drug out of developing countries, NY Times reports
VRTX Vertex Pharmaceuticals - 05/04/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/01/23
- Fly Intel: After-Hours Movers
- 03/21/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/09/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
VRTX Vertex Pharmaceuticals - 05/01/23
- Vertex options imply 3.8% move in share price post-earnings
- 02/07/23
- Vertex options imply 3.7% move in share price post-earnings
|
Initiation
| ShowHide Related Items >><< - 04:49 Today Piper Sandler
- Acelyrin initiated with an Overweight at Piper Sandler
|